Clinical Trial

Cleaner Long-tErm Assessment Registry - Venous Insights and Efficacy With eXtended Tracking

Study acronym: CLEAR-VIEW XT
Recruiting
View on ClinicalTrials.gov →
Summary
The primary objective of this clinical investigation is to evaluate the safety and effectiveness of the Cleaner Vac® Thrombectomy System for the treatment of thrombus in patients with lower extremity proximal deep vein thrombosis (DVT). This prospective, multi-center, open-label study will assess clinical outcomes, device performance, and procedural success in a single DVT study cohort.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2025-07-28; most recent amendment 2026-06-12.
Status change: Not Yet Recruiting → Recruiting 2025-12-12
Trial Details
NCT Number NCT07102160
Lead Sponsor Argon Medical Devices
Collaborators: Avania, Medical Metrics Diagnostics, Inc
Conditions Deep Vein Thrombosis (DVT), Thrombus in the Peripheral Venous Vasculature, Venous Embolism, Thrombus in the Central and Peripheral Circulatory System, Including Saphenous Vein Grafts
Enrollment 185 participants
Start Date 2026-02-04
Primary Completion 2029-06 (estimated)
Study Completion 2029-06 (estimated)
Updated on ClinicalTrials.gov 2026-06-16